Cortisone and dexamethasone inhibit myogenesis by modulating the AKT/mTOR signaling pathway in C2C12

Jonggun Kim, Min Young Park, Hyung Kwan Kim, Yeonhwa Park, Kwang Youn Whang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Myogenesis occurs in both the prenatal and postnatal periods and the prenatal myogenesis is related to the postnatal myogenesis and the incidence of disease later in life. Glucocorticoids used as therapeutic agents for many diseases, but cause adverse effects on muscle homeostasis, including defects in fetal muscle development. The action of glucocorticoids on differentiated skeletal muscle was well studied, but their effects on myotube formation have not been well investigated. Dexamethasone (DEX) and cortisone (COR), two synthetic therapeutic glucocorticoids, suppress myotube formation in C2C12 cells. Both COR and DEX attenuated myotube formation through modulation of myogenic regulatory factors. In addition, they affected the IGF/PI3K/AKT/mTOR signaling pathway, resulting in increased proteolytic protein (atrogin-1 and MURF1) for muscle degradation and decreased ribosomal S6 phosphorylation. The current results conclude that COR and DEX inhibit myotube formation in C2C12 cells by modulating both the myogenic program via MRFs and protein metabolism via IGF/PI3K/AKT/mTOR signaling pathway.

Original languageEnglish
Pages (from-to)2093-2099
Number of pages7
JournalBioscience, Biotechnology and Biochemistry
Volume80
Issue number11
DOIs
Publication statusPublished - 2016

Fingerprint

Muscle Development
Cortisone
Skeletal Muscle Fibers
Dexamethasone
Muscle
Glucocorticoids
Phosphatidylinositol 3-Kinases
Myogenic Regulatory Factors
S 6
Muscles
Phosphorylation
Fetal Development
Metabolism
Skeletal Muscle
Proteins
Homeostasis
Modulation
Degradation
Defects
Incidence

Keywords

  • C2C12
  • Cortisone
  • Dexamethasone
  • Glucocorticoid
  • Myogenesis

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biotechnology
  • Biochemistry
  • Applied Microbiology and Biotechnology
  • Molecular Biology
  • Organic Chemistry

Cite this

Cortisone and dexamethasone inhibit myogenesis by modulating the AKT/mTOR signaling pathway in C2C12. / Kim, Jonggun; Park, Min Young; Kim, Hyung Kwan; Park, Yeonhwa; Whang, Kwang Youn.

In: Bioscience, Biotechnology and Biochemistry, Vol. 80, No. 11, 2016, p. 2093-2099.

Research output: Contribution to journalArticle

Kim, Jonggun ; Park, Min Young ; Kim, Hyung Kwan ; Park, Yeonhwa ; Whang, Kwang Youn. / Cortisone and dexamethasone inhibit myogenesis by modulating the AKT/mTOR signaling pathway in C2C12. In: Bioscience, Biotechnology and Biochemistry. 2016 ; Vol. 80, No. 11. pp. 2093-2099.
@article{f66afb09602845179d976c6b10ec57df,
title = "Cortisone and dexamethasone inhibit myogenesis by modulating the AKT/mTOR signaling pathway in C2C12",
abstract = "Myogenesis occurs in both the prenatal and postnatal periods and the prenatal myogenesis is related to the postnatal myogenesis and the incidence of disease later in life. Glucocorticoids used as therapeutic agents for many diseases, but cause adverse effects on muscle homeostasis, including defects in fetal muscle development. The action of glucocorticoids on differentiated skeletal muscle was well studied, but their effects on myotube formation have not been well investigated. Dexamethasone (DEX) and cortisone (COR), two synthetic therapeutic glucocorticoids, suppress myotube formation in C2C12 cells. Both COR and DEX attenuated myotube formation through modulation of myogenic regulatory factors. In addition, they affected the IGF/PI3K/AKT/mTOR signaling pathway, resulting in increased proteolytic protein (atrogin-1 and MURF1) for muscle degradation and decreased ribosomal S6 phosphorylation. The current results conclude that COR and DEX inhibit myotube formation in C2C12 cells by modulating both the myogenic program via MRFs and protein metabolism via IGF/PI3K/AKT/mTOR signaling pathway.",
keywords = "C2C12, Cortisone, Dexamethasone, Glucocorticoid, Myogenesis",
author = "Jonggun Kim and Park, {Min Young} and Kim, {Hyung Kwan} and Yeonhwa Park and Whang, {Kwang Youn}",
year = "2016",
doi = "10.1080/09168451.2016.1210502",
language = "English",
volume = "80",
pages = "2093--2099",
journal = "Bioscience, Biotechnology and Biochemistry",
issn = "0916-8451",
publisher = "Japan Society for Bioscience Biotechnology and Agrochemistry",
number = "11",

}

TY - JOUR

T1 - Cortisone and dexamethasone inhibit myogenesis by modulating the AKT/mTOR signaling pathway in C2C12

AU - Kim, Jonggun

AU - Park, Min Young

AU - Kim, Hyung Kwan

AU - Park, Yeonhwa

AU - Whang, Kwang Youn

PY - 2016

Y1 - 2016

N2 - Myogenesis occurs in both the prenatal and postnatal periods and the prenatal myogenesis is related to the postnatal myogenesis and the incidence of disease later in life. Glucocorticoids used as therapeutic agents for many diseases, but cause adverse effects on muscle homeostasis, including defects in fetal muscle development. The action of glucocorticoids on differentiated skeletal muscle was well studied, but their effects on myotube formation have not been well investigated. Dexamethasone (DEX) and cortisone (COR), two synthetic therapeutic glucocorticoids, suppress myotube formation in C2C12 cells. Both COR and DEX attenuated myotube formation through modulation of myogenic regulatory factors. In addition, they affected the IGF/PI3K/AKT/mTOR signaling pathway, resulting in increased proteolytic protein (atrogin-1 and MURF1) for muscle degradation and decreased ribosomal S6 phosphorylation. The current results conclude that COR and DEX inhibit myotube formation in C2C12 cells by modulating both the myogenic program via MRFs and protein metabolism via IGF/PI3K/AKT/mTOR signaling pathway.

AB - Myogenesis occurs in both the prenatal and postnatal periods and the prenatal myogenesis is related to the postnatal myogenesis and the incidence of disease later in life. Glucocorticoids used as therapeutic agents for many diseases, but cause adverse effects on muscle homeostasis, including defects in fetal muscle development. The action of glucocorticoids on differentiated skeletal muscle was well studied, but their effects on myotube formation have not been well investigated. Dexamethasone (DEX) and cortisone (COR), two synthetic therapeutic glucocorticoids, suppress myotube formation in C2C12 cells. Both COR and DEX attenuated myotube formation through modulation of myogenic regulatory factors. In addition, they affected the IGF/PI3K/AKT/mTOR signaling pathway, resulting in increased proteolytic protein (atrogin-1 and MURF1) for muscle degradation and decreased ribosomal S6 phosphorylation. The current results conclude that COR and DEX inhibit myotube formation in C2C12 cells by modulating both the myogenic program via MRFs and protein metabolism via IGF/PI3K/AKT/mTOR signaling pathway.

KW - C2C12

KW - Cortisone

KW - Dexamethasone

KW - Glucocorticoid

KW - Myogenesis

UR - http://www.scopus.com/inward/record.url?scp=84992699743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992699743&partnerID=8YFLogxK

U2 - 10.1080/09168451.2016.1210502

DO - 10.1080/09168451.2016.1210502

M3 - Article

AN - SCOPUS:84992699743

VL - 80

SP - 2093

EP - 2099

JO - Bioscience, Biotechnology and Biochemistry

JF - Bioscience, Biotechnology and Biochemistry

SN - 0916-8451

IS - 11

ER -